Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.72 |
| ▸ | MEN1 | O00255 | 6/20 | 0.72 |
| ▸ | USP2 | O75604 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | RECQL | P46063 | 1/20 | 0.72 |
| ▸ | IDO1 | P14902 | 4/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | MIF | P14174 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CRHBP | P24387 | 1/20 | 0.51 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.51 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25343177 | 0.84 | MEN1 (0.77) | KMT2AMEN1USP2HTTRECQL | |
| SCHEMBL443977 | 0.84 | MEN1 (1.00) | KMT2AMEN1USP2HTTRECQL | |
| SCHEMBL300125 | 0.81 | IDO1 (1.00) | KMT2AMEN1HTTIDO1ALDH1A1 | |
| SCHEMBL5457508 | 0.81 | NPC1 (0.50) | KMT2AMEN1USP2HTTRECQL | |
| SCHEMBL4309629 | 0.78 | MAPT (0.62) | KMT2AMEN1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL17781757 | 0.78 | MEN1 (0.67) | KMT2AMEN1USP2HTTRECQL | |
| SCHEMBL298137 | 0.76 | GSTP1 (0.72) | IDO1GSTM2 | |
| SCHEMBL28069116 | 0.76 | GSTM2 (0.68) | KMT2AMEN1USP2HTTRECQL | |
| SCHEMBL7318993 | 0.76 | MAPT (0.68) | KMT2AMEN1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL22705040 | 0.75 | IDO1 (0.55) | KMT2AMEN1USP2HTTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| US-20220241203-A1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIVERSIDADE DO MINHO (PT) | 2022-08-04 | — | — | US | disclosed |
| EP-3283879-B1 | METHOD FOR DETECTING ONE OR MORE ANALYTES IN A SAMPLE, SAID DETECTION BEING DELIMITED BY A REACTION CHAMBER | ATTOMOL GMBH MOLEKULARE DIAGNOSTIKA (DE) | 2019-03-27 | — | — | EP | disclosed |
| EP-3283879-A1 | METHOD FOR DETECTING ONE OR MORE ANALYTES IN A SAMPLE, SAID DETECTION BEING DELIMITED BY A REACTION CHAMBER | Attomol GmbH Molekulare Diagnostika (DE) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016166295-A1 | METHOD FOR DETECTING ONE OR MORE ANALYTES IN A SAMPLE, SAID DETECTION BEING DELIMITED BY A REACTION CHAMBER | ATTOMOL GMBH MOLEKULARE DIAGNOSTIKA (DE) | 2016-10-20 | — | — | WO | disclosed |
| EP-2167964-B1 | METHOD FOR CARRYING OUT AND EVALUATING MIX&MEASURE ASSAYS FOR THE MEASUREMENT OF REACTION KINETICS, CONCENTRATIONS AND AFFINITIES OF ANALYTES IN MULTIPLEX FORMAT | ATTOMOL GMBH MOLEKULARE DIAGNOSTIKA (DE) | 2015-03-11 | — | — | EP | disclosed |
| US-20120122896-A1 | 2,1,3-BENZOXADIAZOL DERIVATIVES FOR THE INHIBITION OF INFLUENZA A AND B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS REPLICATION | PIKE PHARMA GMBH (CH) | 2012-05-17 | — | — | US | disclosed |
| US-20120039813-A1 | INTRINSICALLY COLORED, LUMINESCENT SILK FIBROIN AND A METHOD OF PRODUCING THE SAME | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-02-16 | — | — | US | disclosed |
| US-20110275523-A1 | METHODS AND KITS FOR ANALYZING POLYNUCLEOTIDE SEQUENCES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-11-10 | — | — | US | disclosed |
| US-7981604-B2 | Methods and kits for analyzing polynucleotide sequences | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-07-19 | — | — | US | disclosed |
| EP-0250119-A2 | Atherosclerotic anti-idiotype antibody immunoassay and reagents | VASOCOR (US) | 1987-12-23 | — | — | EP | disclosed |
| EP-0248630-A2 | Atherosclerotic plaque antigen immunoassay | VASOCOR (US) | 1987-12-09 | — | — | EP | disclosed |
| EP-0124103-A2 | Fluorometric assay of chymopapain and reagents therefor | BioWhittaker, Inc. (US) | 1984-11-07 | — | — | EP | disclosed |
| US-4277437-A | CHEMILUMINESCENT SOURCE, QUENCHER MOLECULE | SYVA COMPANY (US) | 1981-07-07 | — | — | US | disclosed |
| US-4235869-A | ANTIBODY FRAGMENTS MONOVALENT RECEPTOR | SYVA COMPANY (US) | 1980-11-25 | — | — | US | disclosed |
| US-4233402-A | CHEMICAL ANALYSIS OF A BINDING PAIR OF LIGANDS AND ENZYMES BY LIGHT SIGNALS | SYVA COMPANY (US) | 1980-11-11 | — | — | US | disclosed |
| US-4220450-A | Chemically induced fluorescence immunoassay | SYVA COMPANY (US) | 1980-09-02 | — | — | US | disclosed |
| US-4199559-A | DETERMINING THE PRESENCE OR AMOUNT OF A LIGAND OR ANTIBODIES | SYVA COMPANY (US) | 1980-04-22 | — | — | US | disclosed |
| US-4174384-A | Fluorescence quenching with immunological pairs in immunoassays | SYVA COMPANY (US) | 1979-11-13 | — | — | US | disclosed |
| US-3996345-A | Fluorescence quenching with immunological pairs in immunoassays | SYVA COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122896-A1 | 2,1,3-BENZOXADIAZOL DERIVATIVES FOR THE INHIBITION OF INFLUENZA A AND B VIRUS AND RESPIRATORY SYNCYTIAL VIRUS REPLICATION | TENT4B, IRF3, MAVS | KMT2A 1674/4885MEN1 4597/4885USP2 1795/4885 |
| US-20120039813-A1 | INTRINSICALLY COLORED, LUMINESCENT SILK FIBROIN AND A METHOD OF PRODUCING THE SAME | IK, FGB, VIP | KMT2A 4547/4885MEN1 1459/4885USP2 1265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.